VolitionRx Limited VNRX
0.20 USD -0.03 (-13.13%)
Regular-session close
0.21 +0.01 +4.10%
After hours · Nov 16, 7:57 PM ET
0.1902 Day range 0.229
0.16 52-week range 7.80
- YTD
- -96.16%
- 1 year
- -96.97%
News
prnewswire.com Volition Expands Contract with Fujifilm to Include the Nu.Q® Vet Test for Cats Expansion extends potential use of Nu.Q® technology to Japan's almost nine million cats Volition expects Nu.Q® Vet Feline Test to be the world's first simple, affordable blood-based liquid biopsy…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Akanda (NASDAQ:AKAN) shares increased by 55.1% to $2.11 during Monday's pre-market session. The market value of their outstanding shares is at $3.5 million. Alpha Tau Medical (NASDAQ:DRTS)…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers InflaRx (NASDAQ:IFRX) stock rose 12.7% to $1.32 during Friday's after-market session. The market value of their outstanding shares is at $182.6 million. Instinct Bio Technical Co…
seekingalpha.com VolitionRx Limited (VNRX) Q3 2026 Earnings Call Transcript VolitionRx Limited (VNRX) Q3 2026 Earnings Call Transcript
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Cerenome (NASDAQ:CNSY) shares rose 39.5% to $1.07 during Friday's regular session. The market value of their outstanding shares is at $5.8 million. As per the press release, Q3 earnings came…benzinga.com VolitionRX Q3 EPS $(0.21) Beats $(0.40) Estimate, Sales $1.614M Beat $706.500K Estimate VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.40) by 47.5 percent. This is a 79 percent increase over losses of $(1.00) per…
prnewswire.com VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Friday, November 13 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
prnewswire.com VolitionRx Limited Schedules Third Quarter 2026 Earnings Conference Call and Business Update Conference call to take place on Friday, November 13 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.benzinga.com VolitionRx Executes Non-Binding Letter Of Intent With Missionpharma A/S To Develop, Roll Out Volition's Prototype Lateral Flow Technology For NETosis VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has executed a non-binding Letter of Intent ("LOI") with Missionpharma A/S, a Danish global
benzinga.com VolitionRx Makes $500K Cash Partial Prepayment Towards Outstanding Principal Balance On Its Senior Secured Convertible Promissory Note Note dated January 15, 2026, in the original principal amount of $2,400,000 (the "Note"), issued to Lind Global Asset Management XII LLC ("Lind"). Following the partial pre-payment, the remaining
